Taysha Gene Therapies, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 5.5M | 0 | 2.0M | 2.3M | 2.0M | 1.8M | 1.1M |
| Cost of Goods Sold | 295K | 299K | 286K | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -295K | 5.2M | -286K | 2.0M | 2.3M | 2.0M | 1.8M | 1.1M |
| R&D Expenses | 33.8M | 24.7M | 25.5M | 20.1M | 15.6M | 15.3M | 14.9M | 15.1M |
| Operating Expenses | 43.2M | 33.5M | 33.7M | 28.7M | 23.7M | 22.0M | 27.7M | 22.4M |
| Operating Income | -43.5M | -28.3M | -34.0M | -26.8M | -21.4M | -19.9M | -25.9M | -21.3M |
| Other Income / Gains | 1.1M | 449K | 1.3M | -129K | -108K | 1.1M | 374K | 371K |
| Net Income | -42.4M | -27.9M | -32.7M | -26.9M | -21.5M | -18.8M | -25.5M | -20.9M |
| EPS (Diluted) | -0.12 | -0.08 | -0.093 | -0.09 | -0.08 | -0.092 | -0.095 | -0.09 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0.945 | 0 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 9.7M | 8.8M | 8.3M | 8.6M | 8.2M | 6.6M | 7.9M | 7.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 9.7M | 8.8M | 8.3M | 8.6M | 8.2M | 6.6M | 7.9M | 7.3M |
| Other Expenses | -295K | 0 | 0 | 0 | 0 | 0 | 4.8M | 0 |
| Cost And Expenses | 43.5M | 33.8M | 34.0M | 28.7M | 23.7M | 22.0M | 27.7M | 22.4M |
| Interest Income | 2.6M | 2.9M | 3.2M | 1.9M | 1.3M | 1.7M | 2.1M | 1.4M |
| Interest Expense | 9K | 12K | 15K | 17K | 19K | 22K | 24K | 27K |
| Depreciation And Amortization | 295K | 299K | 286K | 277K | 283K | 304K | 294K | 322K |
| Ebitda | -42.1M | -28.0M | -32.4M | -26.6M | -21.2M | -18.5M | -25.2M | -20.6M |
| Ebitdaratio | 0 | -5.105 | 0 | -13.388 | -9.221 | -9.129 | -14.097 | -18.506 |
| Operating Income Ratio | 0 | -5.16 | 0 | -13.471 | -9.305 | -9.858 | -14.484 | -19.154 |
| Income Before Tax | -42.4M | -27.9M | -32.7M | -26.9M | -21.5M | -18.8M | -25.5M | -20.9M |
| Income Before Tax Ratio | 0 | -5.078 | 0 | -13.536 | -9.352 | -9.29 | -14.275 | -18.82 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | -5.078 | 0 | -13.536 | -9.352 | -9.29 | -14.275 | -18.82 |
| Epsdiluted | -0.12 | -0.08 | -0.093 | -0.09 | -0.08 | -0.092 | -0.095 | -0.09 |
| Weighted Average Shs Out | 366.6M | 319.7M | 353.3M | 298.0M | 269.3M | 204.9M | 267.8M | 232.8M |
| Weighted Average Shs Out Dil | 366.6M | 319.7M | 353.3M | 298.0M | 269.3M | 204.9M | 267.8M | 232.8M |